11.22
Schlusskurs vom Vortag:
$10.98
Offen:
$10.95
24-Stunden-Volumen:
253.34K
Relative Volume:
0.68
Marktkapitalisierung:
$314.04M
Einnahmen:
$30.43M
Nettoeinkommen (Verlust:
$-18.15M
KGV:
-16.26
EPS:
-0.69
Netto-Cashflow:
$-9.08M
1W Leistung:
+0.63%
1M Leistung:
-0.36%
6M Leistung:
-37.39%
1J Leistung:
+55.62%
Clearpoint Neuro Inc Stock (CLPT) Company Profile
Firmenname
Clearpoint Neuro Inc
Sektor
Branche
Telefon
(949) 900-6833
Adresse
120 S. SIERRA AVENUE, SOLANA BEACH, CA
Vergleichen Sie CLPT mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
CLPT
Clearpoint Neuro Inc
|
11.22 | 315.15M | 30.43M | -18.15M | -9.08M | -0.69 |
![]()
ABT
Abbott Laboratories
|
125.73 | 228.77B | 43.11B | 13.98B | 6.66B | 7.98 |
![]()
BSX
Boston Scientific Corp
|
103.16 | 153.09B | 17.55B | 2.03B | 2.72B | 1.37 |
![]()
SYK
Stryker Corp
|
395.15 | 149.27B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
91.65 | 114.31B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
76.30 | 45.06B | 5.54B | 4.18B | 623.10M | 7.00 |
Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-07-25 | Fortgesetzt | B. Riley Securities | Buy |
2023-10-24 | Eingeleitet | Stifel | Buy |
2023-02-16 | Fortgesetzt | B. Riley Securities | Buy |
2022-04-05 | Fortgesetzt | B. Riley Securities | Buy |
2021-03-18 | Eingeleitet | Lake Street | Buy |
2020-07-17 | Eingeleitet | B. Riley FBR | Buy |
Alle ansehen
Clearpoint Neuro Inc Aktie (CLPT) Neueste Nachrichten
ClearPoint Neuro Inc. Stock Analysis and ForecastFree Stock Market Forecast Reports - Autocar Professional
What drives ClearPoint Neuro Inc. stock priceConsistently high returns - jammulinksnews.com
What analysts say about ClearPoint Neuro Inc. stockSuperior risk-adjusted returns - jammulinksnews.com
What makes ClearPoint Neuro Inc. stock price move sharplyFree Risk Assessment Services - Newser
How ClearPoint Neuro Inc. stock performs during market volatilityDaily Gain Forecast - Newser
Where are the Opportunities in (CLPT) - news.stocktradersdaily.com
Is ClearPoint Neuro Inc. a good long term investmentSkyrocketing returns - jammulinksnews.com
How high can ClearPoint Neuro Inc. stock price go in 2025Free Access to Community - Newser
Why ClearPoint Neuro Inc. stock attracts strong analyst attentionFree Stock Market Practical Discussion Forums - Newser
ClearPoint Neuro (NASDAQ:CLPT) Downgraded by Wall Street Zen to Sell - Defense World
(CLPT) Proactive Strategies - news.stocktradersdaily.com
CLPT SEC FilingsClearpoint Neuro Inc 10-K, 10-Q, 8-K Forms - Stock Titan
ClearPoint Neuro, Inc.(NasdaqCM: CLPT) added to Russell Small Cap Completeness Index - MarketScreener
ClearPoint Neuro, Inc.(NasdaqCM: CLPT) added to Russell 3000 Growth Index - MarketScreener
(CLPT) Investment Analysis - news.stocktradersdaily.com
ClearPoint Neuro: Consumables Growth Is Promising (NASDAQ:CLPT) - Seeking Alpha
ClearPoint Neuro: A Strategic Stake in Gene Therapy's Next Frontier - AInvest
(CLPT) On The My Stocks Page - news.stocktradersdaily.com
ClearPoint Neuro Expands with New Lease Agreement - TipRanks
ClearPoint Neuro May 2025 presentation: Enters ’Fast Forward’ phase after Q1 revenue beat - Investing.com
Critical Comparison: T2 Biosystems (NASDAQ:TTOO) vs. ClearPoint Neuro (NASDAQ:CLPT) - Defense World
ClearPoint Neuro (NASDAQ:CLPT) Upgraded by Wall Street Zen to “Hold” Rating - Defense World
Two Sigma Investments LP Makes New $159,000 Investment in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
ClearPoint Neuro director sells $132,800 in stock By Investing.com - Investing.com Canada
ClearPoint Neuro director sells $132,800 in stock - Investing.com
ClearPoint Neuro CEO Joseph Burnett sells shares worth $282k By Investing.com - Investing.com India
ClearPoint Neuro CEO Joseph Burnett sells shares worth $282k - Investing.com
ClearPoint Neuro Inc (CLPT) Shares Down 3.01% on Jun 11 - GuruFocus
Finanzdaten der Clearpoint Neuro Inc-Aktie (CLPT)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):